oral insulin
Asset
Activates insulin receptors to regulate glucose uptake and metabolism
- Stage
- Phase 1
- Modality
- Protein or enzyme
- Target
- Insulin/IGF-1 signalling
- 1
- Indication
- 212
- Trials
- 1
- Developer
Indications
1Type 1 diabetes
Phase 1, Recruiting, NCT07634770, clinicaltrials.gov, 7 Oct 2026
In the full profile
- Targets and what it contains4
- Owner and partners1
- Trials212
- Evidence for its targets4
- Competitors12
- Aging relevance1
- Signals15
Every asset’s record: target, stage, trials and the evidence behind it.